#begin document (ectb_1029_2); part 000
ectb_1029	2	0	Fever	NN	(TOP(NP*	-	-	-	-	-
ectb_1029	2	1	chips	NNS	*))	chip	-	11	-	-

ectb_1029	2	0	DR.	NNP	(TOP(S(NP*	-	-	-	-	(3
ectb_1029	2	1	Chip	NNP	*	-	-	-	-	-
ectb_1029	2	2	Bio-technology	NNP	*)	-	-	-	-	3)
ectb_1029	2	3	was	VBD	(VP*	be	03	-	-	-
ectb_1029	2	4	set	VBN	(VP*	set	03	-	-	-
ectb_1029	2	5	up	RP	(PRT*)	-	-	-	-	-
ectb_1029	2	6	in	IN	(PP*	-	-	-	-	-
ectb_1029	2	7	September	NNP	(NP*	-	-	-	-	-
ectb_1029	2	8	1998	CD	*))))	-	-	-	-	-
ectb_1029	2	9	.	.	*))	-	-	-	-	-

ectb_1029	2	0	Vice	NNP	(TOP(S(NP(NML*	-	-	-	-	(35
ectb_1029	2	1	president	NN	*)	president	-	1	-	-
ectb_1029	2	2	Wang	NNP	*	-	-	-	-	-
ectb_1029	2	3	Shin	NNP	*	-	-	-	-	-
ectb_1029	2	4	-	HYPH	*	-	-	-	-	-
ectb_1029	2	5	hwan	NNP	*)	-	-	-	-	35)
ectb_1029	2	6	states	VBZ	(VP*	state	01	1	-	-
ectb_1029	2	7	that	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	8	the	DT	(S(NP*	-	-	-	-	(3
ectb_1029	2	9	company	NN	*)	company	-	1	-	3)
ectb_1029	2	10	successfully	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	11	applied	VBD	(VP*	apply	01	3	-	-
ectb_1029	2	12	to	IN	(PP*	-	-	-	-	-
ectb_1029	2	13	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	14	Ministry	NNP	*)	-	-	-	-	-
ectb_1029	2	15	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	16	Economic	NNP	(NP*	-	-	-	-	-
ectb_1029	2	17	Affairs	NNPS	*))))	-	-	-	-	-
ectb_1029	2	18	for	IN	(PP*	-	-	-	-	-
ectb_1029	2	19	funding	NN	(NP(NP*)	fund	-	1	-	-
ectb_1029	2	20	to	TO	(SBAR(S(VP*	-	-	-	-	-
ectb_1029	2	21	help	VB	(VP*	help	01	1	-	-
ectb_1029	2	22	it	PRP	(NP*)	-	-	-	-	(3)
ectb_1029	2	23	pursue	VB	(S(VP*	pursue	01	1	-	-
ectb_1029	2	24	a	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	25	development	NN	*	-	-	-	-	-
ectb_1029	2	26	program	NN	*)	program	-	3	-	-
ectb_1029	2	27	for	IN	(PP*	-	-	-	-	-
ectb_1029	2	28	enterovirus	NN	(NP(NP*	-	-	-	-	-
ectb_1029	2	29	detection	NN	*	-	-	-	-	-
ectb_1029	2	30	chips	NNS	*)	chip	-	11	-	-
ectb_1029	2	31	and	CC	*	-	-	-	-	-
ectb_1029	2	32	test	NN	(NP*	test	-	1	-	-
ectb_1029	2	33	technology	NN	*))))))))))))))))	technology	-	1	-	-
ectb_1029	2	34	.	.	*))	-	-	-	-	-

ectb_1029	2	0	Today	NN	(TOP(S(NP*)	today	-	2	-	-
ectb_1029	2	1	,	,	*	-	-	-	-	-
ectb_1029	2	2	the	DT	(S(NP*	-	-	-	-	-
ectb_1029	2	3	enterovirus	NN	*	-	-	-	-	-
ectb_1029	2	4	chip	NN	*)	chip	-	11	-	-
ectb_1029	2	5	is	VBZ	(VP*	be	01	1	-	-
ectb_1029	2	6	in	IN	(PP*	-	-	-	-	-
ectb_1029	2	7	the	DT	(NP*	-	-	-	-	-
ectb_1029	2	8	testing	NN	*	-	-	-	-	-
ectb_1029	2	9	phase	NN	*))))	phase	-	1	-	-
ectb_1029	2	10	,	,	*	-	-	-	-	-
ectb_1029	2	11	and	CC	*	-	-	-	-	-
ectb_1029	2	12	DR.	NNP	(S(NP*	-	-	-	-	(3
ectb_1029	2	13	Chip	NNP	*)	-	-	-	-	3)
ectb_1029	2	14	is	VBZ	(VP*	be	03	-	-	-
ectb_1029	2	15	collaborating	VBG	(VP*	collaborate	01	1	-	-
ectb_1029	2	16	with	IN	(PP*	-	-	-	-	-
ectb_1029	2	17	Taipei	NNP	(NP*	-	-	-	-	-
ectb_1029	2	18	Veterans	NNPS	*	-	-	-	-	-
ectb_1029	2	19	General	NNP	*	-	-	-	-	-
ectb_1029	2	20	Hospital	NNP	*))	-	-	-	-	-
ectb_1029	2	21	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	2	22	obtain	VB	(VP*	obtain	01	1	-	-
ectb_1029	2	23	samples	NNS	(NP(NP*)	-	-	-	-	-
ectb_1029	2	24	with	IN	(SBAR(WHPP*	-	-	-	-	-
ectb_1029	2	25	which	WDT	(WHNP*))	-	-	-	-	-
ectb_1029	2	26	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	2	27	establish	VB	(VP*	establish	01	-	-	-
ectb_1029	2	28	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	29	accuracy	NN	*)	-	-	-	-	-
ectb_1029	2	30	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	31	the	DT	(NP*	-	-	-	-	-
ectb_1029	2	32	chip	NN	*))))))))))))))	chip	-	11	-	-
ectb_1029	2	33	.	.	*))	-	-	-	-	-

ectb_1029	2	0	What	WP	(TOP(SBARQ(WHNP*)	-	-	-	-	-
ectb_1029	2	1	is	VBZ	(SQ(VP*	be	01	1	-	-
ectb_1029	2	2	so	RB	(ADJP*	-	-	-	-	-
ectb_1029	2	3	remarkable	JJ	*)	-	-	-	-	-
ectb_1029	2	4	about	IN	(PP*	-	-	-	-	-
ectb_1029	2	5	the	DT	(NP*	-	-	-	-	-
ectb_1029	2	6	enterovirus	NN	*	-	-	-	-	-
ectb_1029	2	7	detection	NN	*	-	-	-	-	-
ectb_1029	2	8	chip	NN	*))	chip	-	11	-	-
ectb_1029	2	9	when	WRB	(SBAR(WHADVP*)	-	-	-	-	-
ectb_1029	2	10	compared	VBN	(S(VP*	compare	01	2	-	-
ectb_1029	2	11	with	IN	(PP*	-	-	-	-	-
ectb_1029	2	12	traditional	JJ	(NP*	-	-	-	-	-
ectb_1029	2	13	test	NN	*	test	-	1	-	-
ectb_1029	2	14	methods	NNS	*)))))))	-	-	-	-	-
ectb_1029	2	15	?	.	*))	-	-	-	-	-

ectb_1029	2	0	There	EX	(TOP(S(NP*)	-	-	-	-	-
ectb_1029	2	1	are	VBP	(VP*	be	02	3	-	-
ectb_1029	2	2	68	CD	(NP(NP*	-	-	-	-	-
ectb_1029	2	3	known	JJ	*	-	-	-	-	-
ectb_1029	2	4	forms	NNS	*)	form	-	5	-	-
ectb_1029	2	5	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	6	non-polio	JJ	(NP*	-	-	-	-	-
ectb_1029	2	7	enterovirus	NN	*))))	-	-	-	-	-
ectb_1029	2	8	.	.	*))	-	-	-	-	-

ectb_1029	2	0	The	DT	(TOP(S(NP*	-	-	-	-	-
ectb_1029	2	1	detection	NN	*	-	-	-	-	-
ectb_1029	2	2	chip	NN	*)	chip	-	11	-	-
ectb_1029	2	3	does	VBZ	(VP(VP*	do	01	-	-	-
ectb_1029	2	4	not	RB	*	-	-	-	-	-
ectb_1029	2	5	simply	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	6	determine	VB	(VP*	determine	01	1	-	-
ectb_1029	2	7	whether	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	8	a	DT	(S(NP*	-	-	-	-	-
ectb_1029	2	9	person	NN	*)	person	-	1	-	-
ectb_1029	2	10	is	VBZ	(VP*	be	01	1	-	-
ectb_1029	2	11	infected	JJ	(ADJP*	-	-	-	-	-
ectb_1029	2	12	with	IN	(PP*	-	-	-	-	-
ectb_1029	2	13	enterovirus	NN	(NP*))))))))	-	-	-	-	-
ectb_1029	2	14	,	,	*	-	-	-	-	-
ectb_1029	2	15	but	CC	*	-	-	-	-	-
ectb_1029	2	16	can	MD	(VP*	-	-	-	-	-
ectb_1029	2	17	also	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	18	differentiate	VB	(VP*	differentiate	01	1	-	-
ectb_1029	2	19	between	IN	(PP*	-	-	-	-	-
ectb_1029	2	20	different	JJ	(NP*	-	-	-	-	-
ectb_1029	2	21	virus	NN	*	-	-	-	-	-
ectb_1029	2	22	groups	NNS	*))	group	-	1	-	-
ectb_1029	2	23	,	,	*	-	-	-	-	-
ectb_1029	2	24	for	IN	(S(PP*	-	-	-	-	-
ectb_1029	2	25	instance	NN	(NP*))	-	-	-	-	-
ectb_1029	2	26	showing	VBG	(VP*	show	01	1	-	-
ectb_1029	2	27	whether	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	28	a	DT	(S(NP*	-	-	-	-	-
ectb_1029	2	29	sample	JJ	*)	-	-	-	-	-
ectb_1029	2	30	contains	VBZ	(VP*	contain	01	1	-	-
ectb_1029	2	31	the	DT	(NP(NP*	-	-	-	-	(7
ectb_1029	2	32	deadly	JJ	*	-	-	-	-	-
ectb_1029	2	33	Entero	NNP	(NML*	-	-	-	-	-
ectb_1029	2	34	71	NNP	*)	-	-	-	-	-
ectb_1029	2	35	virus	NN	*)	-	-	-	-	7)
ectb_1029	2	36	,	,	*	-	-	-	-	-
ectb_1029	2	37	or	CC	*	-	-	-	-	-
ectb_1029	2	38	Coxsackie	NNP	(NP(NP*	-	-	-	-	-
ectb_1029	2	39	A16	NNP	*)	-	-	-	-	-
ectb_1029	2	40	,	,	*	-	-	-	-	-
ectb_1029	2	41	which	WDT	(SBAR(WHNP*)	-	-	-	-	-
ectb_1029	2	42	is	VBZ	(S(VP*	be	03	-	-	-
ectb_1029	2	43	easily	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	44	confused	VBN	(VP*	confuse	01	-	-	-
ectb_1029	2	45	with	IN	(PP*	-	-	-	-	-
ectb_1029	2	46	Entero	NNP	(NP*	-	-	-	-	(7
ectb_1029	2	47	71	NNP	*))))))))))))))))	-	-	-	-	7)
ectb_1029	2	48	.	.	*))	-	-	-	-	-

ectb_1029	2	0	In	IN	(TOP(S(PP*	-	-	-	-	-
ectb_1029	2	1	addition	NN	(NP*))	addition	01	6	-	-
ectb_1029	2	2	,	,	*	-	-	-	-	-
ectb_1029	2	3	the	DT	(NP(NP*	-	-	-	-	(33
ectb_1029	2	4	chip	NN	*)	chip	-	11	-	33)
ectb_1029	2	5	and	CC	*	-	-	-	-	-
ectb_1029	2	6	its	PRP$	(NP*	-	-	-	-	(33)
ectb_1029	2	7	accompanying	VBG	*	accompany	01	-	-	-
ectb_1029	2	8	PCR	NNP	*	-	-	-	-	-
ectb_1029	2	9	kit	NN	*))	-	-	-	-	-
ectb_1029	2	10	greatly	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	11	reduce	VBP	(VP*	reduce	01	1	-	-
ectb_1029	2	12	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	13	time	NN	*)	time	-	3	-	-
ectb_1029	2	14	required	VBN	(VP*	require	01	-	-	-
ectb_1029	2	15	for	IN	(PP*	-	-	-	-	-
ectb_1029	2	16	testing	NN	(NP*)))))	test	-	1	-	-
ectb_1029	2	17	.	.	*))	-	-	-	-	-

ectb_1029	2	0	Wang	NNP	(TOP(S(S(NP*	-	-	-	-	(35
ectb_1029	2	1	Shin	NNP	*	-	-	-	-	-
ectb_1029	2	2	-	HYPH	*	-	-	-	-	-
ectb_1029	2	3	hwan	NNP	*)	-	-	-	-	35)
ectb_1029	2	4	notes	VBZ	(VP*	note	01	1	-	-
ectb_1029	2	5	that	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	6	traditional	JJ	(S(NP*	-	-	-	-	-
ectb_1029	2	7	bacterial	JJ	(ADJP*	-	-	-	-	-
ectb_1029	2	8	and	CC	*	-	-	-	-	-
ectb_1029	2	9	viral	JJ	*)	-	-	-	-	-
ectb_1029	2	10	cultures	NNS	*)	culture	-	1	-	-
ectb_1029	2	11	take	VBP	(VP*	take	10	3	-	-
ectb_1029	2	12	seven	CD	(NP(QP*	-	-	-	-	-
ectb_1029	2	13	to	IN	*	-	-	-	-	-
ectb_1029	2	14	ten	CD	*)	-	-	-	-	-
ectb_1029	2	15	days	NNS	*)	day	-	4	-	-
ectb_1029	2	16	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	2	17	prepare	VB	(VP*))))))))	prepare	02	2	-	-
ectb_1029	2	18	,	,	*	-	-	-	-	-
ectb_1029	2	19	and	CC	*	-	-	-	-	-
ectb_1029	2	20	even	RB	(S(PP(ADVP*)	-	-	-	-	-
ectb_1029	2	21	with	IN	*	-	-	-	-	-
ectb_1029	2	22	the	DT	(NP*	-	-	-	-	-
ectb_1029	2	23	newer	JJR	*	-	-	-	-	-
ectb_1029	2	24	molecular	JJ	(NML*	-	-	-	-	-
ectb_1029	2	25	biology	NN	*)	-	-	-	-	-
ectb_1029	2	26	testing	NN	*	-	-	-	-	-
ectb_1029	2	27	techniques	NNS	*))	technique	-	3	-	-
ectb_1029	2	28	it	PRP	(NP*)	-	-	-	-	-
ectb_1029	2	29	takes	VBZ	(VP*	take	10	3	-	-
ectb_1029	2	30	three	CD	(NP*	-	-	-	-	-
ectb_1029	2	31	days	NNS	*)	day	-	2	-	-
ectb_1029	2	32	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	2	33	get	VB	(VP*	get	01	1	-	-
ectb_1029	2	34	a	DT	(NP*	-	-	-	-	-
ectb_1029	2	35	result	NN	*))))))	result	-	2	-	-
ectb_1029	2	36	.	.	*))	-	-	-	-	-

ectb_1029	2	0	But	CC	(TOP(S*	-	-	-	-	-
ectb_1029	2	1	DR.	NNP	(NP*	-	-	-	-	(3
ectb_1029	2	2	Chip	NNP	*)	-	-	-	-	3)
ectb_1029	2	3	has	VBZ	(VP*	have	01	-	-	-
ectb_1029	2	4	developed	VBN	(VP*	develop	02	2	-	-
ectb_1029	2	5	methods	NNS	(NP(NP*)	-	-	-	-	-
ectb_1029	2	6	to	TO	(SBAR(S(VP*	-	-	-	-	-
ectb_1029	2	7	reduce	VB	(VP*	reduce	01	1	-	-
ectb_1029	2	8	the	DT	(NP*	-	-	-	-	-
ectb_1029	2	9	sample	NN	*	-	-	-	-	-
ectb_1029	2	10	preparation	NN	*	preparation	-	1	-	-
ectb_1029	2	11	time	NN	*))))))	time	-	3	-	-
ectb_1029	2	12	,	,	*	-	-	-	-	-
ectb_1029	2	13	which	WDT	(SBAR(WHNP*)	-	-	-	-	-
ectb_1029	2	14	enables	VBZ	(S(VP*	enable	01	1	-	-
ectb_1029	2	15	a	DT	(NP*	-	-	-	-	-
ectb_1029	2	16	result	NN	*)	result	-	2	-	-
ectb_1029	2	17	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	2	18	be	VB	(VP*	be	03	-	-	-
ectb_1029	2	19	obtained	VBN	(VP*	obtain	01	-	-	-
ectb_1029	2	20	in	IN	(PP*	-	-	-	-	-
ectb_1029	2	21	only	RB	(NP(QP*	-	-	-	-	-
ectb_1029	2	22	six	CD	*)	-	-	-	-	-
ectb_1029	2	23	hours	NNS	*))	hour	-	1	-	-
ectb_1029	2	24	when	WRB	(SBAR(WHADVP*)	-	-	-	-	-
ectb_1029	2	25	used	VBN	(S(VP*	use	01	-	-	-
ectb_1029	2	26	in	IN	(PP*	-	-	-	-	-
ectb_1029	2	27	combination	NN	(NP(NP*)	combination	-	1	-	-
ectb_1029	2	28	with	IN	(PP*	-	-	-	-	-
ectb_1029	2	29	their	PRP$	(NP*	-	-	-	-	(3)
ectb_1029	2	30	enterovirus	NN	*	-	-	-	-	-
ectb_1029	2	31	chip	NN	*))))))))))))))))	chip	-	11	-	-
ectb_1029	2	32	.	.	*))	-	-	-	-	-

ectb_1029	2	0	Furthermore	RB	(TOP(S(ADVP*)	-	-	-	-	-
ectb_1029	2	1	,	,	*	-	-	-	-	-
ectb_1029	2	2	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	3	initial	JJ	*	-	-	-	-	-
ectb_1029	2	4	results	NNS	*)	result	-	2	-	-
ectb_1029	2	5	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	6	joint	JJ	(NP(NP*	-	-	-	-	-
ectb_1029	2	7	trials	NNS	*)	trial	01	1	-	-
ectb_1029	2	8	by	IN	(PP*	-	-	-	-	-
ectb_1029	2	9	DR.	NNP	(NP(NP*	-	-	-	-	(3
ectb_1029	2	10	Chip	NNP	*)	-	-	-	-	3)
ectb_1029	2	11	,	,	*	-	-	-	-	-
ectb_1029	2	12	Chang	NNP	(NP(NML*	-	-	-	-	-
ectb_1029	2	13	Gung	NNP	*)	-	-	-	-	-
ectb_1029	2	14	University	NNP	*)	-	-	-	-	-
ectb_1029	2	15	and	CC	*	-	-	-	-	-
ectb_1029	2	16	National	NNP	(NP*	-	-	-	-	-
ectb_1029	2	17	Cheng	NNP	(NML*	-	-	-	-	-
ectb_1029	2	18	Kung	NNP	*)	-	-	-	-	-
ectb_1029	2	19	University	NNP	*))))))	-	-	-	-	-
ectb_1029	2	20	suggest	VBP	(VP*	suggest	01	2	-	-
ectb_1029	2	21	that	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	22	the	DT	(S(NP*	-	-	-	-	-
ectb_1029	2	23	chip	NN	*)	chip	-	11	-	-
ectb_1029	2	24	is	VBZ	(VP*	be	01	1	-	-
ectb_1029	2	25	over	IN	(ADJP(ADJP(NP(QP*	-	-	-	-	-
ectb_1029	2	26	a	DT	*	-	-	-	-	-
ectb_1029	2	27	thousand	NN	*)	-	-	-	-	-
ectb_1029	2	28	times	NNS	*)	time	-	6	-	-
ectb_1029	2	29	more	RBR	*	-	-	-	-	-
ectb_1029	2	30	sensitive	JJ	*)	-	-	-	-	-
ectb_1029	2	31	than	IN	(PP*	-	-	-	-	-
ectb_1029	2	32	traditional	JJ	(NP*	-	-	-	-	-
ectb_1029	2	33	test	NN	*	test	-	1	-	-
ectb_1029	2	34	methods	NNS	*)))))))	-	-	-	-	-
ectb_1029	2	35	.	.	*))	-	-	-	-	-

ectb_1029	2	0	"	``	(TOP(SINV*	-	-	-	-	-
ectb_1029	2	1	In	IN	(S(PP*	-	-	-	-	-
ectb_1029	2	2	addition	NN	(NP(NP*)	addition	01	6	-	-
ectb_1029	2	3	to	IN	(PP*	-	-	-	-	-
ectb_1029	2	4	enterovirus	NN	(NP*))))	-	-	-	-	-
ectb_1029	2	5	,	,	*	-	-	-	-	-
ectb_1029	2	6	we	PRP	(NP*)	-	-	-	-	(3)
ectb_1029	2	7	plan	VBP	(VP*	plan	01	1	-	-
ectb_1029	2	8	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	2	9	develop	VB	(VP*	develop	02	1	-	-
ectb_1029	2	10	chips	NNS	(NP(NP*)	chip	-	11	-	-
ectb_1029	2	11	to	TO	(SBAR(S(VP*	-	-	-	-	-
ectb_1029	2	12	detect	VB	(VP*	detect	01	1	-	-
ectb_1029	2	13	other	JJ	(NP(NP*	-	-	-	-	-
ectb_1029	2	14	infectious	JJ	*	-	-	-	-	-
ectb_1029	2	15	diseases	NNS	*)	-	-	-	-	-
ectb_1029	2	16	such	JJ	(PP*	-	-	-	-	-
ectb_1029	2	17	as	IN	*	-	-	-	-	-
ectb_1029	2	18	hepatitis	NN	(NP(NP*	-	-	-	-	-
ectb_1029	2	19	B	NNP	*)	-	-	-	-	-
ectb_1029	2	20	,	,	*	-	-	-	-	-
ectb_1029	2	21	hepatitis	NN	(NP*	-	-	-	-	-
ectb_1029	2	22	C	NNP	*)	-	-	-	-	-
ectb_1029	2	23	and	CC	*	-	-	-	-	-
ectb_1029	2	24	HIV	NN	(NP*))))))))))))))	-	-	-	-	-
ectb_1029	2	25	,	,	*	-	-	-	-	-
ectb_1029	2	26	"	''	*	-	-	-	-	-
ectb_1029	2	27	says	VBZ	(VP*)	say	01	1	-	-
ectb_1029	2	28	Wang	NNP	(NP*	-	-	-	-	(35
ectb_1029	2	29	Shin	NNP	*	-	-	-	-	-
ectb_1029	2	30	-	HYPH	*	-	-	-	-	-
ectb_1029	2	31	hwan	NNP	*)	-	-	-	-	35)
ectb_1029	2	32	.	.	*))	-	-	-	-	-

ectb_1029	2	0	Apart	RB	(TOP(S(ADVP*	-	-	-	-	-
ectb_1029	2	1	from	IN	(PP*	-	-	-	-	-
ectb_1029	2	2	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	3	enterovirus	NN	*	-	-	-	-	-
ectb_1029	2	4	chip	NN	*)	chip	-	11	-	-
ectb_1029	2	5	,	,	*	-	-	-	-	-
ectb_1029	2	6	which	WDT	(SBAR(WHNP*)	-	-	-	-	-
ectb_1029	2	7	is	VBZ	(S(VP*	be	01	1	-	-
ectb_1029	2	8	already	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	9	at	IN	(PP*	-	-	-	-	-
ectb_1029	2	10	the	DT	(NP*	-	-	-	-	-
ectb_1029	2	11	testing	NN	*	-	-	-	-	-
ectb_1029	2	12	stage	NN	*))))))))	stage	-	2	-	-
ectb_1029	2	13	,	,	*	-	-	-	-	-
ectb_1029	2	14	the	DT	(NP(NP*	-	-	-	-	(48
ectb_1029	2	15	ITRI	NNP	*	-	-	-	-	-
ectb_1029	2	16	's	POS	*)	-	-	-	-	-
ectb_1029	2	17	Molecular	NNP	*	-	-	-	-	-
ectb_1029	2	18	Biomedical	NNP	*	-	-	-	-	-
ectb_1029	2	19	Technology	NNP	*	-	-	-	-	-
ectb_1029	2	20	Division	NNP	*)	-	-	-	-	48)
ectb_1029	2	21	is	VBZ	(VP*	be	03	-	-	-
ectb_1029	2	22	also	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	23	conducting	VBG	(VP*	conduct	01	2	-	-
ectb_1029	2	24	research	NN	(NP(NP*	research	-	1	-	-
ectb_1029	2	25	and	CC	*	-	-	-	-	-
ectb_1029	2	26	development	NN	*)	-	-	-	-	-
ectb_1029	2	27	on	IN	(PP*	-	-	-	-	-
ectb_1029	2	28	biochip	NN	(NP*	-	-	-	-	-
ectb_1029	2	29	applications	NNS	*	-	-	-	-	-
ectb_1029	2	30	and	CC	*	-	-	-	-	-
ectb_1029	2	31	technology	NN	*)))))	technology	-	1	-	-
ectb_1029	2	32	.	.	*))	-	-	-	-	-

ectb_1029	2	0	Research	NN	(TOP(S(NP(NML*	-	-	-	-	(8
ectb_1029	2	1	program	NN	*	-	-	-	-	-
ectb_1029	2	2	director	NN	*)	-	-	-	-	-
ectb_1029	2	3	Pan	NNP	*	-	-	-	-	-
ectb_1029	2	4	Chao	NNP	*	-	-	-	-	-
ectb_1029	2	5	-	HYPH	*	-	-	-	-	-
ectb_1029	2	6	chi	NNP	*)	-	-	-	-	8)
ectb_1029	2	7	states	VBZ	(VP*	state	01	1	-	-
ectb_1029	2	8	that	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	9	at	IN	(S(PP*	-	-	-	-	-
ectb_1029	2	10	present	NN	(NP*))	present	-	1	-	-
ectb_1029	2	11	they	PRP	(NP*)	-	-	-	-	(48)
ectb_1029	2	12	are	VBP	(VP*	be	03	-	-	-
ectb_1029	2	13	actively	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	14	developing	VBG	(VP*	develop	02	-	-	-
ectb_1029	2	15	a	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	16	"	``	*	-	-	-	-	-
ectb_1029	2	17	fever	NN	*	-	-	-	-	-
ectb_1029	2	18	chip	NN	*	chip	-	11	-	-
ectb_1029	2	19	"	''	*)	-	-	-	-	-
ectb_1029	2	20	with	IN	(PP*	-	-	-	-	-
ectb_1029	2	21	a	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	22	wide	JJ	*	-	-	-	-	-
ectb_1029	2	23	range	NN	*)	range	-	6	-	-
ectb_1029	2	24	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	25	applications	NNS	(NP*))))))))))	-	-	-	-	-
ectb_1029	2	26	.	.	*))	-	-	-	-	-

ectb_1029	2	0	Pan	NNP	(TOP(S(NP*)	-	-	-	-	(8)
ectb_1029	2	1	explains	VBZ	(VP*	explain	01	1	-	-
ectb_1029	2	2	that	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	3	in	IN	(S(PP*	-	-	-	-	-
ectb_1029	2	4	clinical	JJ	(NP*	-	-	-	-	-
ectb_1029	2	5	practice	NN	*))	practice	-	4	-	-
ectb_1029	2	6	,	,	*	-	-	-	-	-
ectb_1029	2	7	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	8	causes	NNS	*)	cause	-	1	-	-
ectb_1029	2	9	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	10	fever	NN	(NP*)))	-	-	-	-	-
ectb_1029	2	11	are	VBP	(VP*	be	01	1	-	-
ectb_1029	2	12	difficult	JJ	(ADJP(ADJP*)	-	-	-	-	-
ectb_1029	2	13	to	TO	(SBAR(S(VP*	-	-	-	-	-
ectb_1029	2	14	quickly	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	15	diagnose	VB	(VP*)))))))))	diagnose	01	2	-	-
ectb_1029	2	16	.	.	*))	-	-	-	-	-

ectb_1029	2	0	A	DT	(TOP(S(S(NP(NP*	-	-	-	-	-
ectb_1029	2	1	"	``	*	-	-	-	-	-
ectb_1029	2	2	fever	NN	*	-	-	-	-	-
ectb_1029	2	3	chip	NN	*	chip	-	11	-	-
ectb_1029	2	4	"	''	*)	-	-	-	-	-
ectb_1029	2	5	bearing	VBG	(VP*	bear	01	4	-	-
ectb_1029	2	6	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	7	DNA	NNP	*)	-	-	-	-	-
ectb_1029	2	8	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	9	common	JJ	(NP*	-	-	-	-	-
ectb_1029	2	10	fever	NN	(ADJP*	-	-	-	-	-
ectb_1029	2	11	-	HYPH	*	-	-	-	-	-
ectb_1029	2	12	causing	VBG	*)	cause	01	1	-	-
ectb_1029	2	13	viruses	NNS	*	-	-	-	-	-
ectb_1029	2	14	and	CC	*	-	-	-	-	-
ectb_1029	2	15	bacteria	NNS	*)))))	-	-	-	-	-
ectb_1029	2	16	could	MD	(VP*	-	-	-	-	-
ectb_1029	2	17	be	VB	(VP*	be	03	-	-	-
ectb_1029	2	18	used	VBN	(VP*	use	01	-	-	-
ectb_1029	2	19	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	2	20	determine	VB	(VP*	determine	01	1	-	-
ectb_1029	2	21	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	22	cause	NN	*)	cause	-	1	-	-
ectb_1029	2	23	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	24	the	DT	(NP*	-	-	-	-	-
ectb_1029	2	25	fever	NN	*))))))))))	-	-	-	-	-
ectb_1029	2	26	and	CC	*	-	-	-	-	-
ectb_1029	2	27	the	DT	(S(NP(NP*	-	-	-	-	-
ectb_1029	2	28	type	NN	*)	type	-	1	-	-
ectb_1029	2	29	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	30	pathogen	NN	(NP(NP*)	-	-	-	-	-
ectb_1029	2	31	involved	VBN	(VP*))))	involve	01	-	-	-
ectb_1029	2	32	would	MD	(VP*	-	-	-	-	-
ectb_1029	2	33	be	VB	(VP*	be	01	1	-	-
ectb_1029	2	34	a	DT	(NP*	-	-	-	-	-
ectb_1029	2	35	valuable	JJ	*	-	-	-	-	-
ectb_1029	2	36	tool	NN	*))))	-	-	-	-	-
ectb_1029	2	37	.	.	*))	-	-	-	-	-

ectb_1029	2	0	However	RB	(TOP(S(ADVP*)	-	-	-	-	-
ectb_1029	2	1	,	,	*	-	-	-	-	-
ectb_1029	2	2	Pan	NNP	(NP*)	-	-	-	-	(8)
ectb_1029	2	3	points	VBZ	(VP*	point	02	1	-	-
ectb_1029	2	4	out	RP	(PRT*)	-	-	-	-	-
ectb_1029	2	5	that	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	6	because	IN	(S(PP*	-	-	-	-	-
ectb_1029	2	7	of	IN	*	-	-	-	-	-
ectb_1029	2	8	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	9	difficulties	NNS	*)	difficulty	-	2	-	-
ectb_1029	2	10	in	IN	(PP*	-	-	-	-	-
ectb_1029	2	11	substantially	RB	(S(ADVP*)	-	-	-	-	-
ectb_1029	2	12	reducing	VBG	(VP*	reduce	01	1	-	-
ectb_1029	2	13	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	14	time	NN	*)	time	-	3	-	-
ectb_1029	2	15	needed	VBN	(VP*	need	01	-	-	-
ectb_1029	2	16	for	IN	(PP*	-	-	-	-	-
ectb_1029	2	17	sample	NN	(NP*	-	-	-	-	-
ectb_1029	2	18	preparation	NN	*)))))))))	preparation	-	1	-	-
ectb_1029	2	19	,	,	*	-	-	-	-	-
ectb_1029	2	20	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	2	21	usefulness	NN	*)	-	-	-	-	-
ectb_1029	2	22	of	IN	(PP*	-	-	-	-	-
ectb_1029	2	23	such	PDT	(NP*	-	-	-	-	(2
ectb_1029	2	24	a	DT	*	-	-	-	-	-
ectb_1029	2	25	fever	NN	*	-	-	-	-	-
ectb_1029	2	26	chip	NN	*)))	chip	-	11	-	2)
ectb_1029	2	27	is	VBZ	(VP*	be	01	1	-	-
ectb_1029	2	28	still	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	29	limited	JJ	(ADJP*)	-	-	-	-	-
ectb_1029	2	30	,	,	*	-	-	-	-	-
ectb_1029	2	31	so	IN	(SBAR*	-	-	-	-	-
ectb_1029	2	32	that	IN	*	-	-	-	-	-
ectb_1029	2	33	it	PRP	(S(NP*)	-	-	-	-	(2)
ectb_1029	2	34	can	MD	(VP*	-	-	-	-	-
ectb_1029	2	35	not	RB	*	-	-	-	-	-
ectb_1029	2	36	yet	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	37	be	VB	(VP*	be	03	-	-	-
ectb_1029	2	38	widely	RB	(ADVP*)	-	-	-	-	-
ectb_1029	2	39	promoted	VBN	(VP*)))))))))	promote	02	-	-	-
ectb_1029	2	40	.	.	*))	-	-	-	-	-

#end document
